RETRACTED ARTICLE: Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients

Abstract Objective Hydroxychloroquine paired with Azithromycin, Vitamin C, Vitamin D, and Zinc (HAZDPac), was used as a multidrug therapy method to treat COVID-19 illness and superimposed secondary bacterial pneumonia. Concerns have been raised though about such combinations regarding cardiac QTc in...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sabine Hazan, Adriana C. Vidal, Nicolas Hulscher, Amelia Goudzwaard, Peter A. McCullough, Alon A. Steinberg
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2024-12-01
Colección:	BMC Cardiovascular Disorders
Materias:	COVID-19 Hydroxychloroquine Azithromycin QTc interval Safety
Acceso en línea:	https://doi.org/10.1186/s12872-024-04376-y
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!